Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
38
XENE Quote, Financials, Valuation and Earnings
Last price:
$38.64
Seasonality move
:
18.17%
Day range:
$38.00 - $39.46
52-week range:
$35.53 - $50.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
222.63x
P/B ratio:
3.70x
Volume:
850.2K
Avg. volume:
423.9K
1-year change:
-5.63%
Market cap:
$2.9B
Revenue:
--
EPS (TTM):
-$2.82
Xenon Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
XENE
Xenon Pharmaceuticals
|
05/09/2024 | 10-Q | 10-Q filing on 05/09/2024 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/08/2023 | 10-Q | 10-Q filing on 11/08/2023 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/09/2023 | 10-Q | 10-Q filing on 08/09/2023 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/08/2022 | 10-Q | 10-Q filing on 11/08/2022 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/10/2021 | 10-Q | 10-Q filing on 11/10/2021 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/11/2021 | 10-Q | 10-Q filing on 08/11/2021 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/11/2021 | 10-Q | 10-Q filing on 05/11/2021 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/05/2020 | 10-Q | 10-Q filing on 11/05/2020 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/06/2020 | 10-Q | 10-Q filing on 08/06/2020 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/26/2020 | 10-Q | 10-Q filing on 05/26/2020 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/22/2020 | 10-Q | 10-Q filing on 05/22/2020 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/21/2020 | 10-Q | 10-Q filing on 05/21/2020 | View Form |
|
XENE
Xenon Pharmaceuticals
|
03/09/2020 | 10-K | 10-K filing on 03/09/2020 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/05/2019 | 10-Q | 10-Q filing on 11/05/2019 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/06/2019 | 10-Q | 10-Q filing on 08/06/2019 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/07/2019 | 10-Q | 10-Q filing on 05/07/2019 | View Form |
|
XENE
Xenon Pharmaceuticals
|
03/06/2019 | 10-K | 10-K filing on 03/06/2019 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/08/2018 | 10-Q | 10-Q filing on 05/08/2018 | View Form |
|
XENE
Xenon Pharmaceuticals
|
03/07/2018 | 10-K | 10-K filing on 03/07/2018 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
XENE
Xenon Pharmaceuticals
|
03/08/2017 | 10-K | 10-K filing on 03/08/2017 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/03/2016 | 10-Q | 10-Q filing on 08/03/2016 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
|
XENE
Xenon Pharmaceuticals
|
03/08/2016 | 10-K | 10-K filing on 03/08/2016 | View Form |
|
XENE
Xenon Pharmaceuticals
|
11/10/2015 | 10-Q | 10-Q filing on 11/10/2015 | View Form |
|
XENE
Xenon Pharmaceuticals
|
08/13/2015 | 10-Q | 10-Q filing on 08/13/2015 | View Form |
|
XENE
Xenon Pharmaceuticals
|
05/12/2015 | 10-Q | 10-Q filing on 05/12/2015 | View Form |
|
XENE
Xenon Pharmaceuticals
|
03/12/2015 | 10-K | 10-K filing on 03/12/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
